Cellnovo Group announce the completion of a worldwide commercial license agreement for the integration and the commercialization of TypeZero’s Artificial Pancreas (AP) technology into Cellnovo’s mobile diabetes management systems. The non-exclusive worldwide agreement allows Cellnovo to commercialize a Cellnovo-TypeZero product in the future. Integration efforts are currently underway with a product launch expected in 2018. No financial terms have been …

Boston Scientific Corporation announced a definitive agreement to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in up-front cash. The Symetis portfolio includes the ACURATE TA™ and ACURATE neo/TF valve* systems for use in the treatment of high-risk patients suffering from severe and symptomatic aortic valve stenosis, …

Select Medical Corporation announced a joint venture agreement with Riverside Health System to operate a long-term acute care hospital and an acute inpatient rehabilitation hospital in Newport News, Virginia.  The agreement also includes the future construction of a new freestanding inpatient rehabilitation hospital in the region. We are honored to partner with Eastern Virginia’s flagship medical system to ensure its …

Bodycad announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bodycad Unicompartmental Knee System, enabling the commercial launch of this truly personalized orthopaedic restoration. Bodycad is the first Canadian company to receive FDA clearance for a joint reconstruction implant system. Bodycad’s revolutionary Unicompartmental Knee System is designed to optimize personalized restoration of the patient’s …

neoSurgical, LTD. is pleased to report the execution of an exclusive distribution agreement with a global partner for the commercialization of neoClose® within Europe. The partner is a world leader in laparoscopic surgery with an extensive product portfolio available worldwide. This agreement anticipates initial product launch in Europe in May 2017. Ronan Keating, neoSurgical’s CTO, stated, “This agreement is an …

International medical imaging IT and cybersecurity company Sectra announces that the University of Pennsylvania Health System (UPHS) will install Sectra PACS in their healthcare enterprise. The Sectra solution, integrated with Epic Radiant and the Epic EMR, will enable access and sharing of images and information across the entire clinical pathway. Additionally, UPHS and Sectra will enter into a development and …

Bracco Diagnostics Inc. announced the launch of its PROTOCO2L TOUCH Colon Insufflator. This device is used to inflate the colon with CO2 in patients who undergo Computed Tomography (CT) Colonography (CTC) for the detection of colon cancer. In the U.S., colon cancer is a leading cause of cancer related deaths. It is recommended that people age 50 and older be …

Northwell Health’s Peconic Bay Medical Center received approval from New York State Health Commissioner Howard Zucker, MD, to establish two laboratory cardiac catheterization and electrophysiology suites, and construct a rooftop helipad. The new “cath labs” will be the first facilities of their kind on the East End, and they have the potential to save hundreds of lives each year. They …

Patients in need of MR imaging at South County Orthopedic Specialists can look forward to high-quality images and an enhanced experience with the recent installation of Toshiba Medical’s VantageTM Elan 1.5T system. The full-service orthopedic care facility in Laguna Woods, Calif. now offers state-of-the-art MR exams that are fast and comfortable thanks to the system’s advanced features that prioritize both …

Dr. Reddy’s Laboratories Limited and Integra LifeSciences Holdings Corporation announced that they have entered into an exclusive distribution agreement. Under the agreement, Dr. Reddy’s will market and distribute DuraGen Plus® and Suturable DuraGen® Dural Regeneration Matrices for use in patients in India. M. V. Ramana, Executive Vice President and Head of Emerging Markets & India Business, Dr. Reddy’s Laboratories said, …